9 min listen
E14: Cardiovascular Safety of Febuxostat
E14: Cardiovascular Safety of Febuxostat
ratings:
Length:
14 minutes
Released:
Mar 25, 2018
Format:
Podcast episode
Description
Today we'll discuss an important trial on febuxostat (ulloric), which raises important concerns about its safety from a cardiovascular perspective. Be sure to tune in to the #RheumJC discussion that will be happening this Thursday!
Released:
Mar 25, 2018
Format:
Podcast episode
Titles in the series (87)
E6: Methylprednisolone and Cyclophosphamide, Alone or in Combinatinon, for Lupus Nephritis: Welcome back! Before we talk about cellcept for lupus nephritis, I decided we should flash back to 1996 and discuss one of the early trials that brought us cyclophosphamide. It's a quick discussion that will help set us up nicely for ALMS this Sunday. ... by The Evidence Based Rheumatology Podcast